发明名称 USE OF LIPOCALIN 2 IN THE REGULATION OF INSULIN SENSITIVITY
摘要 <p>Methods of identifying compounds that modulate lipocalin 2 activity or expression are described, as are methods of reducing insulin resistance or increasing insulin sensitivity by administering compounds that modulate lipocalin 2 expression. Methods of diagnosing insulin resistance or related conditions, by measuring lipocalin 2 activity, are also described.</p>
申请公布号 WO2008030370(A1) 申请公布日期 2008.03.13
申请号 WO2007US18992 申请日期 2007.08.29
申请人 BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;ROSEN, EVAN, D. 发明人 ROSEN, EVAN, D.
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项
地址